癌症的标志 免疫逃避 癌症的标志 免疫逃避
Claudia Galassi1, Timothy A Chan2, Ilio Vitale3
1Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
Cancer cell
|October 11, 2024
概括
癌细胞通过伪装,胁迫和细胞保护来逃避免疫检测. 针对这些"三C"机制是提高癌症免疫疗法和免疫监测有效性的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 主体免疫系统通常会消除早期的癌细胞,保持平衡.
- 癌细胞可以发展出逃避免疫检测和破坏的机制.
- "三个Es"模型描述了免疫控制早期癌症的发展.
研究的目的:
- 介绍和解释癌症免疫规避的新"三C"框架.
- 审查癌症免疫逃避的关键机制.
- 讨论针对癌症免疫规避的治疗策略.
主要方法:
- 关于癌症免疫逃避现有文献的综述.
- 将逃避机制分类为"三个C"框架:伪装,胁迫和细胞保护.
- 讨论治疗影响和未来方向.
主要成果:
- 癌症免疫逃避涉及伪装 (躲避免疫细胞),胁迫 (干扰免疫细胞) 和细胞保护 (抵抗免疫攻击) 的机制.
- 这些机制使得瘤细胞能够逃脱免疫监测,并进展到临床检测到的癌症.
- 针对这些免疫扩散策略可能会恢复抗癌免疫监测.
结论:
- "三C"框架为了解癌症免疫规避提供了一个新的概念模型.
- 阻止癌症免疫逃避对于改善免疫疗法和常规癌症治疗至关重要.
- 针对伪装,胁迫和细胞保护的进一步研究有望促进癌症治疗的进展.
关键词:
T细胞耗尽的情况细胞中的T ((REG) 细胞.抗原呈现的呈现方式.细胞毒性T淋巴细胞树突细胞是一种树突细胞.排除,排除,排除的原因是什么?免疫检查点抑制剂 免疫检查点抑制剂免疫性细胞死亡 免疫性细胞死亡与瘤相关的巨细胞.这是一种I型干扰子.更多相关视频
07:18Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
6.9K
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.5K
相关概念视频
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
